Ertapenem 1000 MG Injection — RxCUI 1734683
RxNorm drug concept · Semantic clinical drug
RxCUI 1734683
Semantic clinical drug · SCD
● Current RxNorm concept 20 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1734683
Official nameErtapenem 1000 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asertapenem 1 GM Injection; ertapenem sodium 1 GM Injection; ertapenem (as ertapenem sodium 1.046 GM) Injection
FDA products mapped20
Package NDCs mapped21
Reported Medicaid activity (SDUD)65,406 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ertapenem Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats moderate to severe bacterial infections in the abdomen, skin, lungs, urinary tract and pelvis. Adults may also get it before elective colorectal surgery to help prevent i...
- A nurse or other professional gives it, usually once a day in adults and teens. It goes into a vein over 30 minutes or into a muscle. Your prescriber decides how long you need it.
- The most common are diarrhea, nausea, headache and irritation where the IV goes in. Children may also have vomiting. Most were mild to moderate.
- Get help for trouble breathing, swelling or other signs of a severe allergy. Also report seizures, tremors or muscle jerks. Call if you get diarrhea that is severe or doesn't go aw...
🕸️ Concept Web — How Ertapenem 1000 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ertapenem 1000 MG Injection
RxCUI 1734683 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ertapenem
325642IN
-
Ertapenem
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Invanz
352721BN
-
Invanz
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ertapenem Injection
1734682SCDF -
Ertapenem Injectable Product
1162505SCDG -
Ertapenem Injection [Invanz]
1734685SBDF -
Invanz Injectable Product
1173448SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Ertapenem Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ertapenem 1000 MG
1734681SCDC -
Ertapenem 1000 MG Injection [Invanz]
1734686SBD -
Ertapenem 1000 MG [Invanz]
1734684SBDC
-
Ertapenem 1000 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ertapenem 1000 MG
SCDC · 1734681 -
Ertapenem Injection
SCDF · 1734682 -
Ertapenem Injectable Product
SCDG · 1162505
Brand-Name Concepts
-
Ertapenem 1000 MG Injection [Invanz]
SBD · 1734686 -
Ertapenem 1000 MG [Invanz]
SBDC · 1734684 -
Ertapenem Injection [Invanz]
SBDF · 1734685 -
Invanz Injectable Product
SBDG · 1173448 -
Invanz
BN · 352721
📦 FDA Products & Package NDCs
20 products · 21 package NDCs
21 package NDCs map to RxCUI 1734683 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00006-3843-71 | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (0006-3843-71) / 1 INJECT... | INVANZ | Merck Sharp & Dohme LLC | 2001-11-21 |
| 00143-9398-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9398-10) / 1 INJECTI... | ertapenem sodium | Hikma Pharmaceuticals USA, Inc. | 2021-08-02 |
| 00143-9429-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9429-10) / 1 INJECTI... | Ertapenem | Hikma Pharmaceuticals USA Inc. | 2025-02-28 |
| 00409-3510-22 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3510-22) / 1 INJECTI... | Ertapenem | Hospira, Inc. | 2020-10-19 |
| 16714-0889-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (16714-889-10) / 1 INJECTI... | ERTAPENEM SODIUM | NorthStar RxLLC | 2021-07-13 |
| 25021-0199-20 | 10 VIAL in 1 CARTON (25021-199-20) / 1 INJECTION, POWDER, L... | Ertapenem | Sagent Pharmaceuticals | 2025-08-15 |
| 25021-0199-66 | 10 VIAL in 1 CARTON (25021-199-66) / 1 INJECTION, POWDER, L... | Ertapenem | Sagent Pharmaceuticals | 2026-01-15 |
| 42023-0221-10 | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (42023-221-10) / 1 INJECT... | ERTAPENEM | ENDO USA, Inc. | 2018-07-26 |
| 42023-0221-85 | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (42023-221-85) / 1 INJECT... | ERTAPENEM | ENDO USA, Inc. | 2018-11-01 |
| 43598-0901-58 | 10 VIAL, SINGLE-DOSE in 1 CARTON (43598-901-58) / 1 INJECTI... | ERTAPENEM SODIUM | Dr.Reddys Laboratories Inc., | 2021-04-29 |
| 44567-0820-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (44567-820-10) / 1 INJECTI... | ertapenem | WG Critical Care, LLC | 2020-01-07 |
| 44647-0051-10 | 10 VIAL in 1 CARTON (44647-051-10) / 20 mL in 1 VIAL (44647... | Ertapenem | Savior Lifetec Corporation | 2019-03-19 |
| 51810-0504-02 | 10 VIAL, SINGLE-DOSE in 1 CARTON (51810-504-02) / 1 INJECTI... | Ertapenem | Qilu Antibiotics Pharmaceutical Co., Ltd. | 2024-10-31 |
| 55150-0282-09 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-282-09) / 1 INJECTI... | Ertapenem | Eugia US LLC | 2018-06-25 |
| 55150-0282-20 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-282-20) / 1 INJECTI... | Ertapenem | Eugia US LLC | 2018-06-25 |
| 60505-6196-04 | 10 VIAL in 1 CARTON (60505-6196-4) / 20 mL in 1 VIAL (60505... | Ertapenem | Apotex Corp | 2019-04-02 |
| 63323-0823-20 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-823-20) / 1 INJECTI... | Ertapenem | Fresenius Kabi USA, LLC | 2019-10-10 |
| 68001-0408-31 | 10 VIAL in 1 CARTON (68001-408-31) / 20 mL in 1 VIAL (68001... | Ertapenem | BluePoint Laboratories | 2019-08-29 |
| 68083-0351-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-351-10) / 1 INJECTI... | Ertapenem | Gland Pharma Limited | 2021-03-26 |
| 72266-0159-05 | 5 VIAL, SINGLE-DOSE in 1 CARTON (72266-159-05) / 1 INJECTIO... | Ertapenem | Fosun Pharma USA Inc | 2022-12-09 |
| 72266-0159-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72266-159-10) / 1 INJECTI... | Ertapenem | Fosun Pharma USA Inc | 2021-11-01 |
Observed labelers:
ENDO USA, Inc. (2) ·
Eugia US LLC (2) ·
Fosun Pharma USA Inc (2) ·
Sagent Pharmaceuticals (2) ·
Apotex Corp (1) ·
BluePoint Laboratories (1)
· +11 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1335 | Ertapenem injection | 16 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.